Mattia D'Agostino Selected Research

Mattia D'Agostino Research Topics

20	Multiple Myeloma 12/2023 - 04/2016
8	Neoplasms (Cancer) 08/2023 - 01/2018
3	Neutropenia 12/2021 - 01/2020
2	Infections 12/2021 - 01/2021
1	Disease Progression 08/2023
1	COVID-19 02/2023
1	Leiomyoma (Uterine Fibroids) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Leiomyosarcoma 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Pneumonia (Pneumonitis) 12/2021
1	Fragile X Syndrome (Martin Bell Syndrome) 11/2021
1	Neurodevelopmental Disorders 11/2021
1	Autism Spectrum Disorder 11/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Circulating Neoplastic Cells 01/2021
1	Residual Neoplasm 12/2020
1	Frailty 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2018
1	Plasma Cell Leukemia 01/2017

5	Monoclonal AntibodiesIBA 12/2023 - 01/2019
4	Bortezomib (Velcade)FDA Link 08/2023 - 12/2020
4	Lenalidomide (CC 5013)FDA Link 12/2021 - 01/2020
3	Melphalan (Alkeran)FDA LinkGeneric 12/2021 - 01/2020
3	daratumumabIBA 12/2021 - 01/2019
3	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 12/2020
2	Proteasome InhibitorsIBA 08/2023 - 01/2019
2	carfilzomibIBA 08/2023 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 01/2020
2	Eukaryotic Initiation Factor-4EIBA 11/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2021
2	Prednisone (Sone)FDA LinkGeneric 12/2020 - 01/2020
2	AntigensIBA 11/2020 - 01/2019
1	SP2509IBA 08/2023
1	GraphiteIBA 02/2023
1	Eukaryotic Translation Initiation Factor 5AIBA 01/2023
1	Fibronectins (Fibronectin)IBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	AlbuminsIBA 01/2022
1	Thalidomide (Thalomid)FDA Link 12/2021
1	PlatinumIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 11/2020
1	Bispecific AntibodiesIBA 11/2020
1	SteroidsIBA 01/2020
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2020
1	Alkylating AgentsIBA 01/2020
1	thiamine triphosphorate (TTP)IBA 01/2020
1	Immunomodulating AgentsIBA 01/2019
1	felzartamabIBA 01/2019
1	isatuximabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2018
1	LigandsIBA 01/2018
1	Investigational DrugsIBA 06/2017

9	Therapeutics 12/2023 - 04/2016
3	Immunotherapy 12/2021 - 01/2017
2	Stem Cell Transplantation 12/2021 - 01/2021
1	Autologous Transplantation 12/2021
1	Transplantation 12/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Salvage Therapy 01/2018